Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19) published in Nature
May 2022: Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19) published in Nature.
The project was awarded £47,940 in the Chief Scientist Office Rapid Research in Covid-19 (RARC-19) funding call to lead a project to investigate Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19).
As a key element in the response to the Covid-19 pandemic, on 25th March the Chief Scientist Office launched the Rapid Research in Covid-19 (RARC-19) funding call. The response from the research community was outstanding, with 17 portfolio bids submitted by institutions across Scotland by the April 8th deadline. In total the portfolios contained 139 individual research project proposals
Cardiac Imaging in SARS Coronavirus disease (CISCO-19)
Brief Summary (Full description can be viewed via Project Summary link on the right)
One-in-four patients with COVID-19 pneumonia develop life-threatening heart problems. Through cardiovascular imaging and biomarkers analyses this study aims to evaluate whether COVID-19 infection results in heart injury. The investigators will also investigate which patients are at risk of heart injury as a result of COVID-19 and why only some patients suffer heart problems as a consequence of the infection. The study will also assess multisystem involvement including the lungs and kidneys.
First published: 23 May 2022